CosmosID

About

CosmosID is a biotechnology company based in Germantown, Maryland, founded in 2008 by Professor Rita Colwell. The company specializes in advanced microbiome analysis and has established itself as a leader in metagenomics. CosmosID offers CLIA-certified, GxP-compliant laboratory services and bioinformatics solutions. In 2023, it merged with Clinical Microbiomics A/S, enhancing its capabilities with multi-omics laboratories and AI-driven analytics. The company provides a range of services, including next-generation sequencing (NGS) and multi-omics solutions for microbiome research across various fields such as health, agriculture, and environmental science. Its bioinformatics services enable precise microbial identification and characterization. CosmosID also offers products like the CosmosID-HUB, a SaaS-based platform for microbiome analysis, and a Metagenomics App that integrates advanced bioinformatics for rapid analysis of microbial communities. The company serves clients in academia, pharmaceuticals, and clinical research, with a global presence in North America and Europe.